Related Experiment Video
Updated: Jun 19, 2026
21:24
Methylated DNA Immunoprecipitation
Published on: January 2, 2009
Epigenetics and cancer treatment
Lasse Sommer Kristensen1, Helene Myrtue Nielsen, Lise Lotte Hansen
1Institute of Human Genetics, The Bartholin Building, University of Aarhus, 8000 Aarhus C, Denmark.
European Journal of Pharmacology
|October 20, 2009
Summary
Epigenetic changes, like DNA methylation, silence tumor suppressor genes in cancer. Epi-drugs targeting DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) can reverse these changes and improve cancer treatments.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer cells exhibit genetic alterations and heritable epigenetic changes affecting gene expression.
- Epigenetic mechanisms, including DNA methylation and histone modifications, are crucial in cancer development.
- Epigenetic changes are potentially reversible using small molecules known as epi-drugs.
Purpose of the Study:
- To review the biological mechanisms of epigenetic silencing of tumor suppressor genes in cancer.
- To explore targeted molecular strategies for reversing epigenetic aberrations.
- To highlight DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) as key epigenetic targets for cancer therapy.
Main Methods:
- Focus on reviewing literature concerning epigenetic silencing mechanisms in cancer.
- Investigate the role of DNMTs and HDACs as therapeutic targets.
- Analyze the synergistic effects of combined DNMT and HDAC inhibition.
- Examine the potential of epi-drugs in sensitizing cancer cells to other treatments.
- Specifically review the restoration of estrogen receptor alpha (ERalpha) activity in breast cancer by DNMT and HDAC inhibitors.
Main Results:
- Epigenetic silencing of tumor suppressor genes is a significant factor in cancer.
- DNMT and HDAC inhibitors show promise in reversing these epigenetic changes.
- Combined inhibition of DNMTs and HDACs demonstrates synergistic effects.
- Epi-drugs enhance the efficacy of various cancer treatment strategies.
- DNMT and HDAC inhibitors can restore ERalpha activity in breast cancer cells.
Conclusions:
- Epigenetic modifications play a critical role in cancer and are potentially targetable.
- DNMT and HDAC inhibitors represent a promising therapeutic avenue for cancer treatment.
- Epigenetic changes, particularly DNA methylation, may serve as valuable biomarkers for predicting treatment response.
Related Concept Videos
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...